Exact Mass: 656.1872
Exact Mass Matches: 656.1872
Found 186 metabolites which its exact mass value is equals to given mass value 656.1872
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Teniposide
A semisynthetic derivative of podophyllotoxin that exhibits antitumor activity. Teniposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent cells from entering into the mitotic phase of the cell cycle, and lead to cell death. Teniposide acts primarily in the G2 and S phases of the cycle. [PubChem] Same as: D02698
Patuletin 3-gentiobioside
Patuletin 3-gentiobioside is found in cauliflower. Patuletin 3-gentiobioside is isolated from spinach (Spinacea oleracea) leaves. Isolated from spinach (Spinacea oleracea) leaves. Patuletin 3-gentiobioside is found in cauliflower and green vegetables.
Quercetagetin 7-methyl ether 3-cellobioside
Quercetagetin 4-methyl ether 7-(6-(E)-caffeylglucoside)
Patuletin 3,7-diglucoside
Mearnsetin 3-galactosyl- (1->4) -galactoside
3,6,7,8,3,4-Hexahydroxy-5-methoxyflavone 7-neohesperidoside
1,3-Di-O-(E)-Caffeoyl-4-O-galloyl-beta-D-glucopyranose
Ptilosaponoside A
{3,4,5-triacetyloxy-6-[5-acetyloxy-3-(4-methoxyphenyl)-4-oxochromen-6-yloxy]-2 H-3,4,5,6-tetrahydropyran-2-yl}methyl acetate
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.339 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.340 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.342
(2R,3S)-4,5,7-tri-O-methylnaringenin-(3alpha->5)-(2S)-2,4,4,6-tetra-O-methylmaesopsin
8-methoxyquercetin-3-O-beta-glucopyranosyl-(1-2)-O-beta-glucopyranoside|corniculatusin-3-O-beta-glucopyranosyl-(1-2)-beta-glucopyranoside|corniculatusin-3-O-beta-sophoroside
2,3,4,6-tetra-O-acetyl-3-O-(E)-p-coumaroylsucrose|3-O-p-coumaroyl-beta-D-fructofuranosyl 2,3,4,6-tetra-O-acetyl-alpha-D-glucopyranoside
4-hydroxy-3,5-dimethoxyphenyl beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranoside|4-hydroxy-3,5-dimethoxyphenyl-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranoside
2,3,4,5,7-pentamethoxy-1-O-primeverosyloxyxanthone
2,3,4,5-tetramethoxy-1-O-gentiobiosyloxyxanthone|2,3,4,5-tetramethoxyxanthone-1-O-gentiobioside
(2RS)-4,4,6-tri-O-methyl-2-deoxymaesopsin-(2->7)-(2RS)-2,4,4,6-tetra-O-methylmaesopsin
6,2,4,6-O-tetraacetyl-3-O-trans-p-coumaroylsucrose
Aplysiatoxin, 29-de(1-hydroxyethyl)-29-(hydroxymethyl)-
patulein 7-O-beta-D-(6-caffeoylglucoside)|tinctosid
3-O-Diglucoside-3,3,4,5,7-Pentahydroxy-6-methoxyflavone
laricitrin 3-O-[beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranoside]
nagilactone C 7-O-beta-D-glucopyranosyl-(1->4)-beta-D-xylopyranoside
6-O-[3-(beta-D-glucopyranosyloxy)-2-hydroxybenzoyl]sweroside
6,3,4,6-tetra-O-acetyl-3-O-(E)-p-coumaroylsucrose|mumeose I
1,3,4,6-tetra-O-acetyl-6-O-p-coumaroylsucrose|prunose II
(2S,3R)-4,5,7-tri-O-methyldihydrogenistein-(2alpha->7)-(2S)-2,4,4,6-tetra-O-methylmaesopsin
3-O-Digalactoside-3,3,4,5,7-Pentahydroxy-6-methoxyflavone
1-O-acetyl-3-O-p-coumaroyl-beta-D-fructofuranosyl 2,3,6-tri-O-acetyl-alpha-D-glucopyranoside
1-O-acetyl-3-O-p-coumaroyl-beta-D-fructofuranosyl 3,4,6-tri-O-acetyl-alpha-D-glucopyranoside
1,6,2,6-O-tetraacetyl-3-O-trans-p-coumaroylsucrose
teniposide
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01C - Plant alkaloids and other natural products > L01CB - Podophyllotoxin derivatives C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C1931 - Antineoplastic Plant Product > C1331 - Epipodophyllotoxin Compound C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C1907 - Drug, Natural Product D004791 - Enzyme Inhibitors
2-[5-[[4-acetyloxy-5-(2,4-dioxopyrimidin-1-yl)-3-(4-hydroxy-2-methoxy-6-methylbenzoyl)oxyoxolan-2-yl]methoxycarbonyl]-2-hydroxyphenoxy]prop-2-enoic acid
2-[5-[[4-acetyloxy-5-(2,4-dioxopyrimidin-1-yl)-3-(4-hydroxy-2-methoxy-6-methylbenzoyl)oxyoxolan-2-yl]methoxycarbonyl]-2-hydroxyphenoxy]prop-2-enoic acid
3,6-bis[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]spiro[2-benzofuran-3,9-xanthene]-1-one
1-(2-(5-(dimethylamino)-1-napthalenesulfonamido)ethyl)-1,4,7,10-tetraazacyclododecane, tetrahydrochloride, dihydrate
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-O-[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl]-L-serine
2-Dibenzothiophen-4-yl-9-[3-(4,6-diphenyl-[1,3,5]triazin-2-yl)-phenyl]-9H-carbazole
2-[[2-chloro-4-[3-chloro-4-[[1-(4-methylanilino)-1,3-dioxobutan-2-yl]diazenyl]phenyl]phenyl]diazenyl]-N-(4-methylphenyl)-3-oxobutanamide
(8aR,9R)-5-[[(4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-thiophen-2-yl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one
[(3S,4R,5R,8S,9S,10S,13R,14S,17R)-4-[(2R,3R,4S,5R,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-sulfooxyoxan-2-yl]oxy-17-ethenyl-10-(hydroxymethyl)-13-methyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate
3-[(8R,13R)-18-[(E)-2-carboxyethenyl]-8,13-bis(carboxymethyl)-3,8,13,17-tetramethyl-7,12-dioxo-21,24-dihydroporphyrin-2-yl]propanoic acid
(2R,4S,5R,6R)-5-acetamido-6-[(1R,2R)-1-acetyloxy-2,3-dihydroxypropyl]-2-[[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-4-hydroxyoxane-2-carboxylic acid
(8aR,9R)-5-[[(2R,4aR,6R,7R,8R)-7,8-dihydroxy-2-thiophen-2-yl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[6,5-f][1,3]benzodioxol-8-one
(5S,5aR,8aR,9S)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-thiophen-2-yl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one
VM-26
A furonaphthodioxole that is a synthetic derivative of podophyllotoxin with anti-tumour activity; causes single- and double-stranded breaks in DNA and DNA-protein cross-links and prevents repair by topoisomerase II binding. Same as: D02698
alpha-N-acetylneuraminyl-2,3-beta-D-galactosyl-1,3-N-acetyl-alpha-D-galactosaminyl group(1-)
Conjugate base of the alpha-N-acetylneuraminyl-2,3-beta-D-galactosyl-1,3-N-acetyl-alpha-D-galactosaminyl group arising from deprotonation of the neuraminosyl carboxy group; major species at pH 7.3.
2-{[3-(acetyloxy)-6-[(acetyloxy)methyl]-4,5-dihydroxyoxan-2-yl]oxy}-2,5-bis[(acetyloxy)methyl]-4-hydroxyoxolan-3-yl 3-(3-hydroxyphenyl)prop-2-enoate
10a,10'a-dimethyl (5s,5'r,6s,6'r,8s,8ar,10as,10'as)-1,1',5,5',8,8',8a-heptahydroxy-6,6'-dimethyl-9,9'-dioxo-5h,5'h,6h,6'h,7h,7'h,8h-[2,2'-bixanthene]-10a,10'a-dicarboxylate
(3,4,5-trihydroxy-6-{[3,5,6-trihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxochromen-7-yl]oxy}oxan-2-yl)methyl 3-(3,4-dihydroxyphenyl)prop-2-enoate
(2s,3r,4s,5s,6r)-2-{[(2s,4r)-4-hydroxy-6-(hydroxymethyl)-2-(4-methoxyphenyl)-8-methyl-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2h-1-benzopyran-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
5-[(acetyloxy)methyl]-2-{[3,5-bis(acetyloxy)-6-[(acetyloxy)methyl]-4-hydroxyoxan-2-yl]oxy}-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl 3-(4-hydroxyphenyl)prop-2-enoate
3-{[(2s,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-methoxychromen-4-one
8,16-dihydroxy-7,15-dimethoxy-6,14-bis[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-2,10-dioxatricyclo[10.4.0.0⁴,⁹]hexadeca-1(16),4,6,8,12,14-hexaene-3,11-dione
(2s,3s,4r,5r)-4-hydroxy-2,5-bis(hydroxymethyl)-2-{[(2r,3r,4s,5r,6r)-3,4,5-tris(acetyloxy)-6-[(acetyloxy)methyl]oxan-2-yl]oxy}oxolan-3-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one
(1s,4ar,5r,7s,7as)-4a,5-dihydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-1h,5h,6h,7ah-cyclopenta[c]pyran-7-yl (2e)-3-phenylprop-2-enoate
(1s,4as,5r,7s,7as)-4a-hydroxy-7-methyl-1,5-bis({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})-1h,5h,6h,7ah-cyclopenta[c]pyran-7-yl (2z)-3-phenylprop-2-enoate
[(1r,3as,3bs,5ar,6r,7s,9as,9bs,11as)-6-{[(2r,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-(sulfooxy)oxan-2-yl]oxy}-1-ethenyl-9a-(hydroxymethyl)-11a-methyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxidanesulfonic acid
2-{[4-hydroxy-6-(hydroxymethyl)-2-(4-methoxyphenyl)-8-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2h-1-benzopyran-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(1r,4as,5r,7r,7as)-4a-hydroxy-7-methyl-1,5-bis({[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})-1h,5h,6h,7ah-cyclopenta[c]pyran-7-yl (2e)-3-phenylprop-2-enoate
2,3,4,5-tetramethoxy-1-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}xanthen-9-one
(9's,10r)-1,4',5',8,9'-pentahydroxy-2',6-dimethyl-10-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-10h-[2,9'-bianthracene]-9,10'-dione
1,3-di-o-(e)-caffeoyl-4-o-galloyl-β-d-gluco-pyranose
{"Ingredient_id": "HBIN001217","Ingredient_name": "1,3-di-o-(e)-caffeoyl-4-o-galloyl-\u03b2-d-gluco-pyranose","Alias": "NA","Ingredient_formula": "C31H28O16","Ingredient_Smile": "C1=CC(=C(C=C1C=CC(=O)OC2C(C(OC(C2OC(=O)C3=CC(=C(C(=C3)O)O)O)CO)OC(=O)C=CC4=CC(=C(C=C4)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5405","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3'-o-β-d-glucopyranosylsyringopicroside
{"Ingredient_id": "HBIN009228","Ingredient_name": "3'-o-\u03b2-d-glucopyranosylsyringopicroside","Alias": "NA","Ingredient_formula": "C30H40O16","Ingredient_Smile": "CC1C2C(CC1=O)C(=COC2OC3C(C(C(C(O3)CO)O)OC4C(C(C(C(O4)CO)O)O)O)O)C(=O)OCCC5=CC=C(C=C5)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "8736","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
4'-o-β-d-glucopyranosylsyringopicroside
{"Ingredient_id": "HBIN010751","Ingredient_name": "4'-o-\u03b2-d-glucopyranosylsyringopicroside","Alias": "NA","Ingredient_formula": "C30H40O16","Ingredient_Smile": "CC1C2C(CC1=O)C(=COC2OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)CO)O)O)O)O)O)C(=O)OCCC5=CC=C(C=C5)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "8737","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6-o-α-d-galactopyranosylharpagoside
{"Ingredient_id": "HBIN012616","Ingredient_name": "6-o-\u03b1-d-galactopyranosylharpagoside","Alias": "NA","Ingredient_formula": "C30H40O16","Ingredient_Smile": "CC1(CC(C2(C1C(OC=C2)OC3C(C(C(C(O3)CO)O)O)O)O)OC4C(C(C(C(O4)CO)O)O)O)OC(=O)C=CC5=CC=CC=C5","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15434","TCMID_id": "8063","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6'-o-α-d-galactopyranosylsyringopicroside
{"Ingredient_id": "HBIN012618","Ingredient_name": "6'-o-\u03b1-d-galactopyranosylsyringopicroside","Alias": "NA","Ingredient_formula": "C30H40O16","Ingredient_Smile": "CC1C2C(CC1=O)C(=COC2OC3C(C(C(C(O3)COC4C(C(C(C(O4)CO)O)O)O)O)O)O)C(=O)OCCC5=CC=C(C=C5)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "8070","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6'-o-α-d-glucopyranosylsyringopicroside
{"Ingredient_id": "HBIN012619","Ingredient_name": "6'-o-\u03b1-d-glucopyranosylsyringopicroside","Alias": "NA","Ingredient_formula": "C30H40O16","Ingredient_Smile": "CC1C2C(CC1=O)C(=COC2OC3C(C(C(C(O3)COC4C(C(C(C(O4)CO)O)O)O)O)O)O)C(=O)OCCC5=CC=C(C=C5)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "8738","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
ardimerin
{"Ingredient_id": "HBIN016630","Ingredient_name": "ardimerin","Alias": "NA","Ingredient_formula": "C28H32O18","Ingredient_Smile": "COC1=C(C2=C(C=C1C3C(C(C(C(O3)CO)O)O)O)C(=O)OC4=C(C=C(C(=C4O)OC)C5C(C(C(C(O5)CO)O)O)O)C(=O)O2)O","Ingredient_weight": "656.54","OB_score": "6.138566995","CAS_id": "546114-44-7","SymMap_id": "SMIT11969","TCMID_id": "NA","TCMSP_id": "MOL011011","TCM_ID_id": "NA","PubChem_id": "44423020","DrugBank_id": "NA"}